Pharmaron Beijing Co Ltd (300759) — Capital Reinvestment Ratio
Pharmaron Beijing Co Ltd (300759) has a Capital Reinvestment Ratio of 0.72x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.04 Billion) in capital expenditures (CN¥746.35 Million). Check tangible net worth ratio of Pharmaron Beijing Co Ltd to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharmaron Beijing Co Ltd Capital Reinvestment Ratio (2014–2024)
This chart tracks Pharmaron Beijing Co Ltd's Capital Reinvestment Ratio across 11 annual periods. For the full cash flow conversion analysis, see Pharmaron Beijing Co Ltd operating cash flow efficiency.
Annual Capital Reinvestment Ratio for Pharmaron Beijing Co Ltd (2014–2024)
Year-by-year Capital Reinvestment Ratio for Pharmaron Beijing Co Ltd from 2014 to 2024. See 300759 free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.79x | CN¥2.58 Billion | CN¥2.04 Billion | ▼ -23.9% |
| 2023 | 1.04x | CN¥2.75 Billion | CN¥2.87 Billion | ▼ -24.4% |
| 2022 | 1.38x | CN¥2.14 Billion | CN¥2.95 Billion | ▲ +35.4% |
| 2021 | 1.02x | CN¥2.06 Billion | CN¥2.09 Billion | ▲ +27.4% |
| 2020 | 0.80x | CN¥1.65 Billion | CN¥1.32 Billion | ▼ -0.7% |
| 2019 | 0.80x | CN¥938.59 Million | CN¥754.61 Million | ▼ -7.5% |
| 2018 | 0.87x | CN¥737.26 Million | CN¥640.99 Million | ▼ -48.6% |
| 2017 | 1.69x | CN¥552.22 Million | CN¥934.67 Million | ▼ -62.2% |
| 2016 | 4.48x | CN¥235.77 Million | CN¥1.06 Billion | ▲ +276.0% |
| 2015 | 1.19x | CN¥216.94 Million | CN¥258.32 Million | ▼ -82.4% |
| 2014 | 6.75x | CN¥12.13 Million | CN¥81.94 Million | — |